The Philippine General Hospital (PGH) has acquired the first state-owned positron emission tomography-computed tomography ...

Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...

Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, ...

Rapport Therapeutics (RAPP) announced results from its positron emission tomography trial and second multiple ascending dose trial for RAP-219.

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

They vie for capacity from the world's most advanced chip fabricator: Taiwan Semiconductor Manufacturing Company. Nvidia may ...

Two anti-transferrin receptor (TfR) nanobodies, V H H123 specific for mouse TfR and V H H188 specific for human TfR (huTfR) were used to track transplants non-invasively by PET/CT in mouse models, ...

Constantinos G. Vayenas discusses how our Universe was made, focusing on positron and electron catalysis of neutrino ...

Artificial intelligence has the potential to improve the analysis of medical image data. For example, algorithms based on deep learning can determine the location and size of tumors. This is the ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...